2022, Innovators: Geoff Martha joined Medtronic in 2011 after a 19-year tenure with GE Healthcare and GE Capital. He succeeded Omar Ishrak as CEO in 2020 and is leading considerable change. Martha broke the business into 20 operating units to operate with greater efficiency. “We need to move faster in everything we do,” Martha says, which would allow Fridley-based Medtronic to introduce new products and therapies into the marketplace more quickly. In 2022, he aims to move Medtronic beyond medical technology, reshaping it into “a leading health care technology company.” By harnessing tech and innovation, Martha wants to improve health outcomes, lower costs, and increase access for patients.
2020, Emerging: When Geoff Martha joined med-tech giant Medtronic in 2011 as senior vice president of strategy and business development, no one knew it had hired a future CEO. But in his eight years at the company, Martha’s had some big assignments. Most recently he was executive vice president and president of Medtronic’s Restorative Therapies Group, a division with more than $8 billion in annual revenue and about 14,000 employees. He takes the reins in late April with the pending retirement of CEO Omar Ishrak. Martha managed the integration of Medtronic with Covidien in 2015—a $50 billion acquisition—the largest med-tech merger in history.